Organizational ways to increase the effectiveness of rehabilitation measures with botulinum toxin

  • Authors: Kizeev M.V.1, Bodunov A.V.2, Nezhkina N.N.3, Novikov A.E.3, Golubeva G.A.4, Kulikova Y.A.4
  • Affiliations:
    1. N. A. Semashko National Research Institute of Public Health
    2. 6Federal State Budgetary Healthcare Institution Reshma Medical Center of the Federal Medical Biological Agency of Russia
    3. Federal State Budgetary Educational Institution of Higher Education «Ivanovo State Medical Academy» of the Ministry of Healthcare of the Russian Federation (FSBEI HE IvSMA MOH Russia)
    4. Federal State Budgetary Healthcare Institution Reshma Medical Center of the Federal Medical Biological Agency of Russia
  • Issue: No 2 (2024)
  • Section: Общественное здоровье и организация здравоохранения
  • URL: http://bulleten-nriph.ru/journal/article/view/2744
  • DOI: https://doi.org/10.25742/NRIPH.2024.02.004
  • Cite item

Abstract


One of the common movement disorders leading to limitation of life activity is spasticity. Medical rehabilitation plays a critical role in treating a patient's spasticity. The article presents an assessment of the organizational model of the sequence of rehabilitation measures using botulinum toxin type A using the example of the Federal State Budgetary Institution Reshma medical center of the FMBA of Russia. A comparative analysis of case histories of patients with spasticity in the arm who received injections of botulinum toxin type A in a 24-hour hospital with a profile of “medical rehabilitation” and a day hospital with a profile of “neurology” for 2022 and the first half of 2023 was carried out. It was determined that the organizational model of the sequence of rehabilitation activities using botulinum toxin type A at the Federal State Budgetary Institution Reshma medical center of the FMBA of Russia is a flexible system that can take into account the individual characteristics of each patient before his admission to the second stage of rehabilitation measures. Botulinum toxin injections can be used both before the second stage of rehabilitation and during the second stage of rehabilitation measures.


About the authors

Mihail V. Kizeev

N. A. Semashko National Research Institute of Public Health

Author for correspondence.
Email: m.kizeev@nriph.ru
ORCID iD: 0000-0002-0293-8372

Russian Federation, 105064, Moscow, Russian Federation;

Aleksandr V. Bodunov

6Federal State Budgetary Healthcare Institution Reshma Medical Center of the Federal Medical Biological Agency of Russia

Email: a.v.bodunov@gmail.com
ORCID iD: 0009-0008-3367-6046

Russian Federation, Ivanovo Region, Russian Federation

Natal`ya N. Nezhkina

Federal State Budgetary Educational Institution of Higher Education «Ivanovo State Medical Academy» of the Ministry of Healthcare of the Russian Federation (FSBEI HE IvSMA MOH Russia)

Email: natanezh@mail.com
ORCID iD: 0000-0002-3731-130X

Russian Federation, Ivanovo, Russian Federation

Aleksandr E. Novikov

Federal State Budgetary Educational Institution of Higher Education «Ivanovo State Medical Academy» of the Ministry of Healthcare of the Russian Federation (FSBEI HE IvSMA MOH Russia)

Email: anovikov52@bmail.ru
ORCID iD: 0000-0003-0561-1161

Russian Federation, Ivanovo, Russian Federation

Galina A. Golubeva

Federal State Budgetary Healthcare Institution Reshma Medical Center of the Federal Medical Biological Agency of Russia

Email: golybevagalia@gmail.com
ORCID iD: 0009-0007-3486-798X

Russian Federation, Ivanovo Region, Russian Federation

Yuliya A. Kulikova

Federal State Budgetary Healthcare Institution Reshma Medical Center of the Federal Medical Biological Agency of Russia

Email: kulikova_sr@mail.ru
ORCID iD: 0009-0006-6356-6716

Russian Federation, Ivanovo Region, Russian Federation

References

  1. Ivanova G.E., Mel`nikova E.V., Belkin A.A., Belyaev A.F., Bodrova R.A., Bujlova T.V., Mal`ceva M.N., MishinaI .E., Prokopenko S.V., Sarana A.M., Staxovskaya L.V., Xasanova D.R., Cykunov M.B., Shamalov N.A., Suvorov A.Yu., Shmonin A.A. How to organize medical rehabilitation? Bulletin of Rehabilitation Medicine. [Vestnik vosstanovitel`noj mediciny]. 2018;2(84):2—12 (in Russian).
  2. Gimigliano F, NegriniS. The World Health Organization «Rehabilitation 2030: a call for action». Eur J Phys Rehabil Med. 2017;53(2):155—168. doi: 10.23736/S1973-9087.17.04746—3
  3. Rivelis Y, Zafar N, MoriceK. Spasticity. In: StatPearls. Treasure Island (FL): StatPearls Publishing; August 8, 2023.
  4. Chang E, Ghosh N, Yanni D, Lee S, Alexandru D, MozaffarT. A Review of Spasticity Treatments: Pharmacological and Interventional Approaches. Crit Rev Phys Rehabil Med. 2013;25(1—2):11—22. doi: 10.1615/CritRevPhysRehabilMed.2013007945
  5. Bochkezanian V, Newton RU, Trajano GS, Blazevich AJ. Effects of Neuromuscular Electrical Stimulation in People with Spinal Cord Injury. Med Sci Sports Exerc. 2018;50(9):1733—1739. doi: 10.1249/MSS.0000000000001637
  6. Emos MC, AgarwalS. Neuroanatomy, Upper Motor Neuron Lesion. In: StatPearls. Treasure Island (FL): StatPearls Publishing; August 14, 2023.
  7. Martino G, Ivanenko Y, Serrao M, et al. Locomotor coordination in patients with Hereditary Spastic Paraplegia. J Electromyogr Kinesiol. 2019;(45):61—69. doi: 10.1016/j.jelekin.2019.02.006
  8. Marsden J, Stevenson V, JarrettL. Treatment of spasticity. Handb Clin Neurol. 2023;(196):497—521. doi: 10.1016/B978-0-323-98817-9.00010—7
  9. Khasanova D.R., Agafonova N.V., Starostina G.Kh., Krylova L.V. Post-stroke spasticity. Consilium Medicum. [Consilium Medicum]. 2016;18(2):31—36 (in Russian).
  10. Wissel J, Ri S, KiviA. Early versus late injections of Botulinumtoxin type A in post-stroke spastic movement disorder: A literature review. Toxicon. 2023;(229):107150. doi: 10.1016/j.toxicon.2023.107150
  11. Santamato A. Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity. Neuropsychiatr Dis Treat. 2016;(12):251—263. doi: 10.2147/NDT.S86978
  12. Elovic EP, Munin MC, Kaňovský P, Hanschmann A, Hiersemenzel R, MarciniakC. Randomized, placebo-controlled trial of incobotulinumtoxina for upper-limb post-stroke spasticity [published correction appears in Muscle Nerve. 2016 Jun;54(1):170]. Muscle Nerve. 2016;53(3):415—421. doi: 10.1002/mus.24776
  13. Antipenko E.A., Gustov A.V. Possibilities and prospects for the use of botulinum toxin in neurological practice. Modern Technologies in Medicine. [Sovremennye tehnologii v medicine]. 2011;(1):102—104 (in Russian).
  14. Ghroubi S, Alila S, Elleuch W, Ayed HB, Mhiri C, Elleuch MH. Efficacy of botulinum toxin A for the treatment of hemiparesis in adults with chronic upper limb spasticity. Pan Afr MedJ. 2020;(35):55. doi: 10.11604/pamj.2020.35.55.16091

Statistics

Views

Abstract - 0

PDF (Russian) - 0

Cited-By


PlumX

Dimensions


Copyright (c) 2025 ФГБНУ Национальный НИИ Общественного здоровья имени Н.А. Семашко

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Mailing Address

Address: 105064, Moscow, st. Vorontsovo Pole, 12, building 1

Email: r.bulletin@yandex.ru

Phone: +7 (495) 917-90-41 add. 136



Principal Contact

Kuzmina Uliia Aleksandrovna
EXECUTIVE SECRETARY
FSSBI «N.A. Semashko National Research Institute of Public Health»

105064, Vorontsovo Pole st., 12, Moscow


Email: r.bulletin@yandex.ru

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies